What You Need To Know About Taxotere Lawsuit

By on 10-20-2016 in Uncategorized

Taxotere is a chemotherapy drug prescribed for breast cancer treatment. It was approved by the Food and Drug Administration in 1996. Since then, taxotere has become the most popular drug used for treating breast cancer. Since then, it has become the most preferred drug prescribed to breast cancer patients. While the drug is effective in extending survival, one of its most glaring side effects is alopecia or permanent hair loss.

While hair loss is a well-known symptom of chemotherapy, it is expected go grow back within 3 – 6 months after stopping treatment. Unfortunately, according to the website of Williams Kherkher, approximately 10 to 15 percent of women who used the drug reported absence of hair growth for as long as ten years after treatment. Studies have revealed that permanent alopecia affects all body hair including eyebrows, eyelashes, and pubic hair.

Aside from hair loss, taxotere is also associated with other side effects, most of which are reversible. In more than 30 percent of the patients, the following side effects happened:

  • Diarrhea
  • Fatigue and weakness
  • Fluid retention
  • Infections
  • Mouth sores
  • Nail changes
  • Nausea
  • Peripheral neuropathy

In 10 to 29 percent of the patients, the following side effects occurred:

  • Muscle, joint, or bone pain
  • Low platelets
  • Liver problems

Sanofi informed other countries of the permanent hair loss side effect of taxotere. In the US, however, the words permanent hair loss or alopecia did not appear in any information published in the US. This was the contention of lawsuits filed against Sanofi-Aventis. The filed case revolved around the following issues:

  • Selling the drug without properly testing it
  • Downplaying the dangers associated with the drug
  • Manufacturing a dangerous drug
  • Not warning patients and health care providers
  • Concealing information from the public
  • Selling the drug without revealing the dangers or risks
  • Failure to determine the safety of the drug
  • Misleading the public in advertising and marketing
  • Manufacturing a dangerous drug

Hair loss has been consistently ranked as one of the most distressing side effects of cancer treatment and can affect well-being and quality of life. It may also affect body image.

Submit a Comment

Your email address will not be published. Required fields are marked *